Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information in Korea.

NCT02663102 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02663102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02663102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information in Korea.
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 20, 2016
Completion date
February 5, 2021
Enrollment
1,388 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human